Owner Scorecard


← All companies ← PTEN Manual PTLO → ← PTCT Pharmaceuticals QUCY →

PTGX, Protagonist Therapeutics Inc.

Pharmaceuticals consumer brand Net current asset value

Protagonist Therapeutics Inc. is an integrated discovery and development company with a validated technology platform.

Our Development Products and Discovery Programs Icotyde (icotrokinra) Icotyde (icotrokinra) is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor ("IL-23R"), which underpins the inflammatory response in psoriasis and offers potential in other IL-23-mediated diseases.

BTD also provides eligibility for priority NDA review, and Orphan Drug status qualifies sponsors for various incentives, including the potential for extended market exclusivity.

Latest annual: FY2025 10-K
PTGX · Protagonist Therapeutics Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$46M
−89.4% YoY · 10% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $282M 5-yr avg $119M
Operating margin 20.7% 5-yr avg −279.2%
ROIC 14% 5-yr avg −41%
Owner-earnings margin 46% 5-yr avg −152%
Free cash flow margin 46% 5-yr avg −152%

Next report By 11/8 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~37 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Net current asset value. Current assets alone exceed every liability combined, and the surplus is most of the balance sheet: the shape Graham called a net-net.
What moves the needle
Operating margin has reached 58% at its best but run negative through the cycle (median −207%) — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Stock-based pay runs about 49% of sales, a real and recurring claim on owners that the GAAP margin understates. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −56%, above 15% in 1 of 9 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2017–2025

realized figures from each filing · older years to the left
2017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$20M$31M$231K$29M$27M$27M$60M$434M$46M$282MRevenueRevenue
59%44%n/m65%99%119%56%10%97%17%SG&A / revenueSG&A/rev
230%192%n/m260%461%475%200%32%346%62%R&D / revenueR&D/rev
($38M)($42M)($81M)($65M)($126M)($131M)($94M)$253M($158M)$58MOperating incomeOp. inc.
−188.9%−136.7%n/m−225.4%−460.0%−494.2%−156.1%58.2%−343.6%20.7%Operating marginOp. mgn
($37M)($40M)($78M)($65M)($126M)($127M)($79M)$279M($129M)Pretax incomePretax
($37M)($39M)($77M)($66M)($126M)($127M)($79M)$275M($130M)$83MNet incomeNet inc.
Cash flow & returns
$4M($50M)($42M)($72M)($108M)($108M)($70M)$184M$58M$131MOperating cash flowOp. cash
$406K$527K$732K$948K$813K$1M$977K$826K$1M$2MDepreciation & amortizationD&A
$36M($18M)$27M($15M)$478K($6M)($22M)($129M)$141M($3M)Working capital & otherWC & other
$666K$486K$967K$471K$1M$795K$609K$1M$2M$615KCapexCapex
3.3%1.6%418.6%1.6%4.0%3.0%1.0%0.3%3.5%0.2%Capex / revenueCapex/rev
$3M($50M)($42M)($73M)($109M)($109M)($71M)$183M$56M$131MOwner earningsOwner earn.
17.3%−163.1%n/m−254.8%−397.3%−409.8%−118.1%42.2%121.9%46.3%Owner earnings marginOE mgn
$3M($50M)($42M)($73M)($109M)($109M)($71M)$183M$56M$131MFree cash flowFCF
16.0%−163.1%n/m−254.8%−398.3%−409.8%−118.1%42.1%121.9%46.3%Free cash flow marginFCF mgn
$16M$2M($54M)($91M)($16M)$91M($39M)($299M)($49M)Investing cash flowInv. cash
$66M$24M$46M$248M$130M$19M$170M$26M$23MFinancing cash flowFin. cash
$146K($177K)($26K)$175K($126K)($90K)Exchange-rate effectFX
$85M($24M)($49M)$84M$6M$2M$61M($89M)$31MChange in cashΔ cash
-205%-110%-112%-31%-56%-115%-49%43%-26%14%ROICROIC
-31%-35%-97%-24%-42%-59%-23%41%-21%10%Return on equityROE
−31%−35%−97%−24%−42%−59%−23%41%−21%10%Retained to equityRetained/eq
Balance sheet
$155M$129M$133M$308M$327M$237M$342M$559M$646M$849MCash & investmentsCash+inv
$1M$6M$3M$3M$2M$4M$772K$2M$5M$3MAccounts payablePayables
$151M$138M$145M$316M$341M$243M$356M$592M$578M$807MCurrent assetsCur. assets
$43M$26M$35M$40M$44M$31M$21M$47M$45M$37MCurrent liabilitiesCur. liab.
3.5×5.3×4.1×7.8×7.7×7.8×16.7×12.5×12.7×21.7×Current ratioCurr. ratio
$879K$861K$2M$1M$2M$2M$1M$3M$4MNet PP&ENet PP&E
$164M$139M$155M$324M$348M$248M$358M$745M$668M$886MTotal assetsAssets
-476.5×-107.9×97.6×Interest coverageInt. cov.
$43M$27M$75M$45M$48M$32M$21M$69M$53MTotal liabilitiesTotal liab.
$121M$113M$80M$280M$300M$216M$337M$675M$615M$842MShareholders’ equityEquity
21.1%22.4%n/m27.6%59.9%91.0%48.8%8.6%99.9%17.7%Stock comp / revenueSBC/rev
Per share
17.7M22.4M25.9M34.4M46.3M49.0M56.8M65.1M63.6M70.8MShares out (diluted)Shares
$1.13$1.38$0.01$0.83$0.59$0.54$1.06$6.68$0.72$3.98Revenue / shareRev/sh
$-2.09$-1.74$-2.98$-1.92$-2.71$-2.60$-1.39$4.23$-2.05$1.17EPS (diluted)EPS
$0.20$-2.26$-1.63$-2.12$-2.35$-2.22$-1.25$2.82$0.88$1.84Owner earnings / shareOE/sh
$0.18$-2.26$-1.64$-2.12$-2.35$-2.22$-1.25$2.81$0.88$1.84Free cash flow / shareFCF/sh
$0.04$0.02$0.04$0.01$0.02$0.02$0.01$0.02$0.03$0.01Cap. spending / shareCapex/sh
$6.82$5.03$3.09$8.13$6.48$4.40$5.93$10.38$9.67$11.88Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
8-yr5-yr
Revenue / share−5.5%/yr−2.8%/yr
Owner earnings / share+20.7%/yr
Capital spending / share−5.0%/yr+12.8%/yr
Book value / share+4.5%/yr+3.5%/yr

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetained

Each year's operating cash, by what management did with it: the mix, and how it drifts.

FY2017FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $130M loss into $56M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025FY2024FY2023FY2022FY2021
Reported net income($130M)$275M($79M)($127M)($126M)
Depreciation & amortizationnon-cash charge added back+$1M+$826K+$977K+$1M+$813K
Stock-based compensationreal costnon-cash, but a real cost+$46M+$38M+$29M+$24M+$16M
Working capital & othertiming of cash in and out, other non-cash items+$141M−$129M−$22M−$6M+$478K
Cash from operations$58M$184M($70M)($108M)($108M)
Maintenance capital expenditurethe spending needed just to hold position and volume−$2M−$826K−$609K−$795K−$813K
Owner earnings$56M$183M($71M)($109M)($109M)
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$529K−$288K
Free cash flow$56M$183M($71M)($109M)($109M)
Owner-earnings marginowner earnings ÷ revenue122%42%-118%-410%-397%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $46M), owner earnings is nearer $10M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • No meaningful interest burden
    Little or no interest expense reported
    What this means

    Little or no interest expense reported, the business isn't leaning on lenders to operate.

  • Net cash
    Cash $128M + ST investments $439M − debt $10M
    What this means

    Cash and short-term investments exceed every dollar of debt by $558M, on net the company owes nothing, and can act from strength when others can't. It also holds $79M in longer-dated marketable securities; counting those, it sits at net cash of $636M. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average through the cycle
    9-yr median, range -205%–43%; -25% latest = NOPAT ($125M) ÷ invested capital $496M
    Industry peers: median -33%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years (it ran -25% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Positive this year, negative across the cycle
    latest $56M = operating cash $58M − maintenance capex $2M (positive this year), after an earlier loss stretch (8-yr median -141%)
    Industry peers: median -70%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 122% of revenue this year, a -141% median across 8 years. Treating stock comp as the real expense it is (less $46M of SBC) leaves $10M.

  • Loss, but cash-generative
    Net income ($130M) · cash from operations $58M
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 1.24×
    Expanding
    Capex $2M ÷ depreciation & amortization as filed $1M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 99.9%
    The count is rising
    Stock compensation $46M (fiscal 2025), 99.9% of revenue · no repurchases · diluted shares +29.6% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 4 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $46M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 12.71×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $10M vs $532M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (9-yr record) · 8 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $0.34/share (latest year $-2.01), the averaged base the calculator's gate runs on, and book value is $9.50/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2017–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 1 of 9
    What this means

    Lost money in 8 year(s), look at what happened there before trusting the average.

  • Operating margin −11728% → −147% (3-yr avg ends)

    In the filing’s words The record and the words agree: the margin widened and the filing attributes the gain to its own pricing, not volume alone.

    What this means

    Through the cycle the operating margin widened — about −11728% early to −147% lately, median −225% — pricing power intact or improving.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Worst year 2019 · −34857.6% op. margin
    What this means

    Operations went underwater in 2019, understand why before trusting the good years.

  • How management talks about it Promotional
    What this means

    The record is compounding, but the filing leans on a promoter’s vocabulary rather than the per-share, return-on-capital terms an owner uses. The results back the talk here; the register is still worth noting.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$807M
  • Cash & short-term investments$783M
  • Other current assets$25M
Current liabilities$37M
  • Accounts payable$3M
  • Other current liabilities$34M
Current ratio21.71×all current assets ÷ what's due · Graham looked for 2×
Quick ratioinventory untagged this quarter, so withheld rather than shown equal to the current ratio
Cash ratio21.05×strictest: cash alone against what's due
Working capital$770Mthe cushion left after near-term bills
Revenue, latest quarter vs. a year ago+3749.2%the freshest read on whether the business is still growing
Current ratio, recent quarters10.7× → 21.7×
Deeper floors
Tangible book value$842Mequity stripped of goodwill & intangibles
Net current asset value$763MGraham's net-net: current assets less all liabilities
Debt incl. operating leases$9M$9M of it operating leases

From the company's latest filing.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearPay, as filed“Actually paid”Owner earnings
2021$5.5M$12.1M($109M)
2022$6.0M−$5.2M($109M)
2023$7.1M$15.3M($71M)
2024$9.5M$17.9M$183M
2025$12.9M$46.1M$56M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership5.2%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • CEO pay ratio30:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$46M

    The slice of the business handed to employees in shares in fiscal 2025, 99.9% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
NKTRNektar Therapeutics$55M81%-265.8%-46%-212%
LXRXLexicon Pharmaceuticals Inc.$50M98%-160.5%-63%-222%
PTGXProtagonist Therapeutics Inc.$46M-207.1%-56%-141%
SEPNSepterna Inc.$46M612.8%2y-28%2y-12968%2y
AQSTAquestive Therapeutics Inc.$45M60%-72.6%-286%1y-62%
WVEWave Life Sciences Ltd.$43M-310.1%-219%
NBTXNanobiotix S.A.$38M-53.6%-70%
BGMBGM Group Ltd.$38M16%3.7%5%1%
Group median-116.5%-51%-176%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Protagonist Therapeutics Inc. has delivered.

$
Base

The assumptions

9.0% = the 4.71% 10-year Treasury (Aug 18, 2026) + 4.29 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · since FY2024−69%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.71%, as of Aug 18, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $131M on 65M shares outstanding, per the 10-Q cover, as of 2026-07-31; net cash $783M. The if-converted diluted count is 71M, 9% above the shares outstanding: the dilution overhang (convertibles, options) a buyer inherits. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Protagonist Therapeutics Inc. (PTGX), the owner's record," https://ownerscorecard.com/c/PTGX, data as of 2026-08-17.

Manual order: ← PTEN its page in the Manual PTLO →

Industry order: ← PTCT the Pharmaceuticals chapter QUCY →